Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I Markers and General Problems of Cancer Adjuvant Therapies

P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year. For some considerable time, the strategy of cancer treatment has been limited to the sophistication...

Full description

Bibliographic Details
Other Authors: Bonadonna, Gianni (Editor), Mathe, G. (Editor), Salmon, S. E. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1979, 1979
Edition:1st ed. 1979
Series:Recent Results in Cancer Research
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • I. Incidence, Kinetics and Markers of Post-Surgical Minimal Residual Disease
  • Kinetics of Minimal Residual Disease
  • Ectopic Production of ACTH, Lipotropin, and ?-Endorphin by Human Cancer Cells. Structurally Related Tumor Markers
  • Prognostic Value of Postoperative Blood Levels of Carcinoembryonic Antigen (CEA) in Breast Cancer
  • ?-Fetoprotein (?FP) as a Marker for Hepatoma and Yolk Sac Tumors
  • Casein and Breast Cancer
  • Prostatic Acid Phosphatase and Prostatic Cancer
  • Sialyl Transferase Activity: A Serum Enzyme Marker in the Follow-Up of Cancer Patients
  • Evidence for Natural Antibodies (IgG) to Poly amines in Human Sera
  • Dynamic and Composition of Cellular Membranes and Serum Lipids in Malignant Disorders
  • Biologic Markers in Neuroblastoma
  • Immune Complexes in Breast Carcinoma
  • Serum Leukocyte Inhibitory Factor in Cancer Patients (Serum LIF)
  • Clinical Evaluation of the Modified Markari Skin Test in Minimal Residual Malignant Disease
  • Multiparametric Markers in the Monitoring of Cancer
  • II. Adjuvant Therapies of Post-Surgical Minimal Residual Disease
  • A. Rational and Experimental Basis of Post-Surgical Residual Therapies
  • Post-Surgical Radiotherapy: Rationale and Methods
  • Possible Drawback of Radiotherapy: Rational and Experimental Bases of Post- Surgical Therapies
  • Adjuvant Chemotherapy: Theoretical Considerations and Modal Studies
  • Design of Adjuvant Chemotherapy Based on Target Cell Determinants of Drug Action: Possibilities and Limitations